Excess imaging translates to "significant" carbon dioxide (CO2) emissions, according to a study published March 28 in the Journal of the...
Men should have prostate-specific membrane antigen (PSMA) PET scans about eight months after undergoing external beam radiotherapy for prostate cancer,...
GE HealthCare (GEHC) will introduce its Revolution Vibe CT system at the American College of Cardiology (ACC) 2025 meeting to...
Novartis has received approval from the U.S. Food and Drug Administration (FDA) for earlier use of Pluvicto to treat patients...
Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter....
AI could help sonographers find fetal abnormalities faster without sacrificing diagnostic quality, according to research published March 27 in the...
Adding thoracic aortic calcification (TAC) data to coronary artery calcification (CAC) AI models shows promise as a risk prediction biomarker...
Radiotherapy developer Actinium Pharmaceuticals is launching ATNM-400, a novel, non-prostate-specific membrane antigen (PSMA) targeting radiotherapy for prostate cancer that uses...
GE HealthCare plans to launch its Flyrcado (flurpiridaz F-18) injection in the U.S. at the 2025 American College of Cardiology (ACC) Annual Scientific...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.